Octaplex Dosing App

Octaplex App

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Apple Mobile Web Clips Icon

Google Font API

HSTS

Amazon

WordPress

nginx

Network Platform Team Owner

Adam America

Owner

Jakob Karner

Melissa Rogers

Michael Holloway

Assistant R&D Board Member/Paralegal R&D/Vendor Manager R&D

Sabine Vogl-Feischl

Vulnerability Management Service Owner

Thiago Maia

Vice President - Head of Corporate Communications

Gavin Montgomery

Sales and Support

Jesse Kiss

SVP National Accounts / Market Access

Neil Herson

Director of Operations

Abbey Chacko

Wolfgang Marguerre

Co-Founder, Chairman & CEO

Marc Rechsteiner

Global Senior Director Corporate Operational & Process Excellence

Rada Brujic

Corporate Logistic Buyer

Pharmaceutical Companies With More Than 500 Employees

University of Heidelberg Alumni Founded Companies

Manufacturing Companies With More Than $500 in Revenue

Europe Companies With More Than $1B in Revenue

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. 

Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Lachen

Schwyz

Switzerland

Europe

Octapharma

Federman & Sherwood Investigates Octapharma Plasma, Inc. for Data Breach

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ...

Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & ...

Intravenous Immunoglobulin Market Expected to Grow at 7.0% CAGR, Reaching USD 24.4 Billion by 2032

Intravenous Immunoglobulin Market Anticipated Worth USD 24.13 Billion by 2032, with a Remarkable 7.50% CAGR...

Plasma Fractionation Market Future Business Opportunities 2024-2031 | CSL Ltd., Octapharma AG, Grifols S.A.

Patients Sue NC Plasma Donation Co. Over Data Breach

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All ...

Propionic Acidemia Treatment Market to See Massive Growth by 2030 | CSL Behring, Octapharma AG, Sanquin ...

Octopharma Plasma's US operations shut down due to suspected ransomware attack

United States

North America

Austria

Italy

France

India

Asia

HTML5

Google Fonts

Google Tag Manager

Bootstrap

jQuery

Google Analytics

Symantec Email Security.Cloud

Apache Server

Google Maps API

Adobe Flash

Octapharma is a global healthcare company specializing in the development and manufacturing of high-quality human protein-based medicines for haematology, immunotherapy, and critical care. The company is family-owned and headquartered in Lachen, Switzerland.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 9, 2024 2:26 AM	106dab8c
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 9, 2024 2:26 AM	e887baf3
company summary	general
signals	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	e69ab0d9
crunchbase profile	general	Oct 30, 2024 1:38 PM	ae015235
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	fb524cc2
peers	general
news basic	general	Mar 9, 2024 2:26 AM	b161c9c9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

OCTA

COM:OCTAPHARMA

Octapharma